44 Participants Needed

Lung Cancer Screening Education for Head and Neck Cancer Survivors

(GUIAR Trial)

CO
Overseen ByCoral Olazagasti
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Miami
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Lung Cancer Screening Education for Head and Neck Cancer Survivors?

Research shows that low-dose computed tomography (LDCT) is effective for lung cancer screening in heavy smokers, improving patient-centered outcomes like quality of life and reducing anxiety. Effective communication and education about screening results, as seen in other studies, can enhance understanding and preparedness, potentially benefiting head and neck cancer survivors as well.12345

Is Lung Cancer Screening Education using Low-Dose Computed Tomography (LDCT) generally safe for humans?

Low-dose computed tomography (LDCT) screening for lung cancer is generally considered safe, with rare harms reported. It is recommended by multiple organizations for high-risk individuals, and careful planning is needed to ensure the benefits outweigh any potential risks.36789

How does lung cancer screening education for head and neck cancer survivors differ from other treatments?

This treatment is unique because it focuses on educating head and neck cancer survivors about lung cancer screening using low-dose computed tomography (LDCT), which is a non-invasive imaging technique that can detect lung cancer early in high-risk individuals. Unlike traditional treatments that directly target cancer, this approach emphasizes prevention and early detection through education and shared decision-making.1011121314

What is the purpose of this trial?

The purpose of this study is to assess the awareness of eligibility of lung cancer screening in Hispanic/LatinX Head and Neck Cancer (HNC) survivors using a survey questionnaire; and to understand the barriers to screening using qualitative interviews.

Research Team

CO

Coral Olazagasti

Principal Investigator

University of Miami

Eligibility Criteria

This trial is for Hispanic/LatinX adults over 18 who are head and neck cancer survivors, treated at least 5 years ago without recurrence. They must meet lung cancer screening criteria: either a history of heavy smoking or fitting the age/smoking profile per USPSTF21/NCCN guidelines. Pregnant/nursing individuals, those with recent lung imaging, active cancers, or less than a 20 pack-year smoking history cannot join.

Inclusion Criteria

I survived head and neck cancer, treated over 5 years ago with no recurrence.
You must consider yourself to be Hispanic/LatinX.
You need to be able to understand and sign a form that explains the study.
See 1 more

Exclusion Criteria

I have had head and neck cancer that spread to distant parts of my body.
I have not had head or neck treatment in the last 5 years.
I have smoked less than 20 pack-years.
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Education and Survey

Participants receive intensive lung cancer screening and tobacco cessation education and complete survey questionnaires to assess awareness and perception of lung cancer screening recommendations

Up to 2 years

Follow-up

Participants are monitored for changes in awareness and perception of lung cancer screening recommendations and undergo early detection lung cancer screening

Up to 2 years

Treatment Details

Interventions

  • Lung Cancer Screening Education
  • Semi-Structured Interview
  • Standard of Care Lung Cancer Screening Program
Trial Overview The study aims to evaluate awareness about lung cancer screening in Hispanic/LatinX head and neck cancer survivors through surveys and interviews. It will also explore barriers to screening participation and provide education on the importance of regular screenings.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Standard of Care Control GroupExperimental Treatment1 Intervention
Participants in this group will receive the standard of care treatment for up to two years.
Group II: Lung Cancer Screening Education GroupExperimental Treatment3 Interventions
Participants in this group will receive intensive lung cancer screening and tobacco cessation education for up to two years.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Miami

Lead Sponsor

Trials
976
Recruited
423,000+

LUNGevity Foundation

Collaborator

Trials
8
Recruited
1,600+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Findings from Research

Lung cancer screening using low-dose computed tomography (LDCT) can cause short-term psychological discomfort, particularly due to false-positive results, but does not significantly impact overall distress or health-related quality of life in the long term.
Negative screening results tend to decrease distress levels, while false positives initially increase distress but return to baseline levels, highlighting the need for effective communication strategies to manage patient anxiety during the screening process.
Patient-centered outcomes among lung cancer screening recipients with computed tomography: a systematic review.Slatore, CG., Sullivan, DR., Pappas, M., et al.[2022]
A study involving 190 patients revealed that while most felt they understood their lung cancer screening results, only 55% actually understood what a lung nodule is, highlighting significant gaps in patient knowledge.
The development of a commonly asked questions (CAQ) information sheet, refined with input from both patients and clinicians, was found to be helpful in improving understanding of lung nodules and incidental findings, suggesting it could enhance communication between patients and healthcare providers.
Patient and Clinician Recommendations to Improve Communication and Understanding of Lung Cancer Screening Results.Crothers, K., Shahrir, S., Kross, EK., et al.[2023]
In a study involving 2,014 participants in a lung cancer screening program, 70.1% remembered receiving a preparatory information booklet about potential LDCT results, with 72.0% finding it quite or very useful.
The booklet helped improve satisfaction with the communication of results, indicating that providing clear written information is beneficial for participants in large-scale lung cancer screening programs.
The SUMMIT Study: Utilising a written 'Next Steps' information booklet to prepare participants for potential lung cancer screening results and follow-up.Bhamani, A., Horst, C., Bojang, F., et al.[2023]

References

Patient-centered outcomes among lung cancer screening recipients with computed tomography: a systematic review. [2022]
Patient and Clinician Recommendations to Improve Communication and Understanding of Lung Cancer Screening Results. [2023]
The SUMMIT Study: Utilising a written 'Next Steps' information booklet to prepare participants for potential lung cancer screening results and follow-up. [2023]
Feasibility of a patient decision aid about lung cancer screening with low-dose computed tomography. [2021]
Screening for Lung Cancer: Lexicon for Communicating With Health Care Providers. [2018]
Patient Adherence in an Academic Medical Center's Low-dose Computed Tomography Screening Program. [2023]
Low-dose Lung Cancer Screening at an Academic Medical Center: Initial Experience and Dose Reduction Strategies. [2019]
An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice. [2022]
Lung Cancer Screening in a Safety-Net Hospital: Rare Harms Inform Decision Making. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Attitudes of Clinicians about Screening Head and Neck Cancer Survivors for Lung Cancer Using Low-Dose Computed Tomography. [2022]
Performance of community-based lung cancer screening program in a Histoplasma endemic region. [2020]
Incorporating lung cancer screening education into tobacco cessation group counseling. [2020]
13.Korea (South)pubmed.ncbi.nlm.nih.gov
Screening for Lung Cancer Using Low-dose Chest Computed Tomography in Korean Long-term Colorectal Cancer Survivors. [2022]
14.United Statespubmed.ncbi.nlm.nih.gov
Perceptions and Utilization of Lung Cancer Screening Among Smokers Enrolled in a Tobacco Cessation Program. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security